Recall Register

Drug recall: Americaine, (benzocaine 20%) Benzocaine Topical Anesthetic Spray, Aerosol Can 2 oz (57 G), Dist. by Insight…

Class I FDA enforcement event 93691. Recall start date: . Status in the FDA record: Completed.

Reason for recall, in the words of FDA

Chemical Contamination: presence of benzene

Class I, in the words of FDA

a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death

Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company started this drug recall on 21 Dec 2023. The firm address in the FDA record is in Tarrytown, NY. FDA put the recall in Class I. FDA event 93691 has 1 product record. The first FDA enforcement report date is 24 Jan 2024. The record gives the status Completed. 90 of the 281 drug events that started in 2023 have more product records. The median drug event of 2023 has 1 product record. The openFDA file has 281 drug events that started in 2023 and 325 that started in 2022.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

Nationwide in the USA

Recalling firm

Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company, Tarrytown, NY.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

1 product record in the event.

FDA event 93691: product records
Recall numberProductQuantityClassStatusReport date
D-0236-2024Americaine, (benzocaine 20%) Benzocaine Topical Anesthetic Spray, Aerosol Can 2 oz (57 G), Dist. by Insight Pharmaceuticals Corp. Tarrytown, NY 10591, USA, A Prestige Consumer Healthcare company. Made in India. NDC 63736-378-02, Can UPC 3 63736 37882 0; Case UPC 1 03 63736 37882 734,704 cansClass ICompleted24 Jan 2024

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class I: The highest of the three FDA recall classes.

The event in context

Drug events that started in 2023
281
Share of these events in Class I
15%
Product records in this event
1Median of the firm: 1
Events of the firm on the register
3

Other events of the firm

Official channels

Cite this page

Recall Register. FDA enforcement event 93691. https://recallregister.com/fda/i/93691/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA drug enforcement reports
Licence
CC0 1.0
Export date
3 Nov 2026
Newest FDA report date on the register
28 Oct 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: Nationwide in the USA
What quantity of product is in FDA event 93691?
The FDA record gives this quantity: 34,704 cans
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many drug recalls of 2023 have the same class?
15% of the 281 drug events that started in 2023 are in Class I.